Evidence map›Paper›PMID 19223666›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2009

Role of glutaredoxin-mediated protein S-glutathionylation in cellular nitroglycerin tolerance.

Pei-Suen Tsou, Vamsi Addanki, Jessica A Haas, Nathaniel A Page, Ho-Leung Fung

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Pei-Suen TsouDepartment of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14260-1200, USA.
Vamsi Addanki
Jessica A Haas
Nathaniel A Page
Ho-Leung Fung
Buffalo State University · USUniversity at Buffalo, State University of New York · US

Funding

Organic Nitrate Metabolism, Tolerance and ActionR01HL081580 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI FUNG, HO-LEUNG · 2006 to 2010
$1.9M
NHLBI NIH HHS HL081580
6 · The paper itself

Abstract

We hypothesize that nitroglycerin (NTG) causes direct oxidation of multiple cellular sulfhydryl (SH) proteins and that manipulation of SH redox status affects NTG tolerance. In LLC-PK1 cells, we found that nitrate tolerance, as indicated by cGMP accumulation toward NTG, was accompanied by increased protein [(35)S]cysteine incorporation, significant S-glutathionylation of multiple proteins, and decreased metabolic activity of several SH-sensitive enzymes, including creatine kinase, xanthine oxidoreductase, and glutaredoxin (GRX). Cells overexpressing GRX exhibited reduced cellular protein S-glutathionylation (PSSG) and absence of NTG tolerance, whereas those with silenced GRX showed increased extent of NTG-induced tolerance. Incubation of LLC-PK1 cells with oxidized glutathione led to several major observations associated with nitrate tolerance, namely, reduced cGMP accumulation, PSSG formation, superoxide accumulation, and the attenuation of these events by vitamin C. Aortic S-glutathionylated proteins increased approximately 3-fold in rats made tolerant in vivo to NTG and showed significant negative correlation with vascular responsiveness ex vivo. NTG incubation in EA.hy926 endothelial cells and LLC-PK1 cells led to increased S-glutathionylation and activity of p21(ras), a known mediator of cellular signaling. These results indicate that the hallmark events of NTG tolerance, such as reduced bioactivation and redox signaling, are associated with GRX-dependent protein deglutathionylation.

Indexed as

AnimalsAorta, ThoracicBlotting, WesternCreatine KinaseCyclic GMPDrug ToleranceEndothelial CellsEnzyme-Linked Immunosorbent AssayGlutaredoxinsGlutathioneHumansLLC-PK1 CellsNitroglycerinOxidation-ReductionProto-Oncogene Proteins p21(ras)RatsCreatine KinaseCyclic GMPGlutaredoxinsGlutathioneHRAS protein, humanNitroglycerinProto-Oncogene Proteins p21(ras)Sulfhydryl CompoundsVasodilator Agents

Identifiers

PMID19223666
PMCPMC2672869
OpenAlexW2111042370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.